UK markets close in 6 hours 26 minutes

GenSight Biologics S.A. (0RIM.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
0.4140+0.0130 (+3.24%)
As of 08:00AM BST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.14
52-week change 3-78.99%
S&P500 52-week change 322.64%
52-week high 32.5300
52-week low 30.0000
50-day moving average 30.4375
200-day moving average 30.5936

Share statistics

Avg vol (3-month) 32.02k
Avg vol (10-day) 35.13k
Shares outstanding 524.38M
Implied shares outstanding 6N/A
Float 844.89M
% held by insiders 111.83%
% held by institutions 113.95%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-5,081.45%

Management effectiveness

Return on assets (ttm)-105.83%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)2.96M
Revenue per share (ttm)0.06
Quarterly revenue growth (yoy)-59.60%
Gross profit (ttm)N/A
EBITDA -28.3M
Net income avi to common (ttm)-26.22M
Diluted EPS (ttm)-0.6330
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.13M
Total cash per share (mrq)0.03
Total debt (mrq)23.54M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.26
Book value per share (mrq)-0.47

Cash flow statement

Operating cash flow (ttm)-24.66M
Levered free cash flow (ttm)-14.13M